Before you give a prescription, give OneOme.
Why OneOme’s RightMed® test?
Over 4 billion prescriptions are issued each year.1 However, not all drugs are effective for all people. In fact, response rates for many drugs are only between 50-75%.2 Adverse drug reactions (ADRs) account for up to 7% of all hospital admissions and up to 20% of re-admissions, according to estimates.3,4 ADRs are the fourth leading cause of death and are estimated to cost $136 billion annually.5 An estimated 10-20% of ADRs may be due to genetic factors.6
Healthcare providers like you may use pharmacogenomic information to make better prescription decisions.
The OneOme RightMed PGx test has the potential to:
Want to learn more about the RightMed test, its benefits, and how to order the test? Download our provider toolkit to learn how you can implement pharmacogenomics into your daily clinical care.
Who should take the OneOme RightMed PGx test?
UNWELCOME SIDE EFFECTS
FROM CURRENT MEDICATIONS
MEDICATIONS THAT ARE
MEDICATIONS FOR ANY OF
THE COVERED MEDICATIONS
RightMed PGx test report and RightMed Advisor
OneOme makes pharmacogenomics accessible and intuitive to providers. With the RightMed pharmacogenomic test, providers receive a clinically actionable report that categorizes drugs into a simple, easy-to-read format. Providers will also have access to the RIGHTMED ADVISOR, an interactive tool to quickly and easily interpret test results, explore more information about the drugs in the OneOme database, evaluate drug-drug interactions, and generate custom reports.
Sample is collected from patient.
OneOme processes the sample and returns the OneOme RightMed pharmacogenomic test report to the provider.
Ready to order?
Get started now by creating your OneOme account. The OneOme provider portal allows you to place orders, download a patient’s clinical test report, and access the rightmed advisor. Connect to our portal to start an order.
Get the latest from OneOme
Find out more about the OneOme pharmacogenomic solution by receiving updates from our team.